Entity Directory · Tracked Subjects

Entity Directory

169 financial instruments tracked across government, finance, and technology — examined for undisclosed conflicts, regulatory capture, and dual loyalties. Search by name, filter by type, jump to a letter, or surface only entities with documented revolving-door transitions.

169on file
1318individuals
817companies & funds
147institutions
Show All (incl. empty) ⟳ Revolving Door ⇩ Download CSV ⇩ JSON
All (6240) Individuals (1318)Companies & Funds (817)Institutions (147)Government Agencies (139)Organisations (3455)Elected Officials (178)Financial Instruments (169)family (1)organisation (2)financial instrument (2)investment firm (3)financial vehicle (2)advocacy organization (7)
ABCDEFGHIJKLMNOPQRSTUVWXYZ#
EA Equitable Community Access to Pharmacist Services Act instrument Bipartisan legislation (H.R. 1770) supported by Sewell to improve reimbursement for community pharmacy services. 0 facts 0 conns 6 sources
G2 Glaucoma Vision Act of 2026 instrument Proposed legislation to expand annual glaucoma screenings and vision research 0 facts 1 conns 0 sources
HA Home Health Stabilization Act instrument Bipartisan legislation introduced by Terri Sewell to prevent Medicare home health funding cuts. 0 facts 1 conns 6 sources
H8 H.R. 8035 instrument Ukraine Security Supplemental Appropriations Act, 2024 0 facts 3 conns 6 sources
H8 H.R. 8070 instrument House-passed version of the Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 0 facts 2 conns 6 sources
IA Improving Care and Access to Nurses (ICAN) Act instrument Legislation (H.R. 2713) aimed at removing physician supervision requirements for CRNAs 0 facts 0 conns 6 sources
IA Increasing Access to Quality Cardiac Rehabilitation Act instrument Bipartisan legislation (S. 717/H.R. 2573) co-sponsored by Terri Sewell to allow PAs and other advanced practice providers to supervise cardiac and pulmonary rehab. 0 facts 0 conns 6 sources
IA Inflation Reduction Act instrument 2022 law capping insulin at $35/month and allowing Medicare drug price negotiation; Steil voted against 0 facts 2 conns 0 sources
KA Kidney PATIENT Act instrument Bipartisan legislation introduced by Sewell to delay the movement of oral-only kidney drugs into a payment bundle, preserving Part D access. 0 facts 0 conns 6 sources
LA Laken Riley Act instrument Legislation requiring mandatory ICE detention for undocumented immigrants charged with certain crimes. 0 facts 5 conns 6 sources
LA Local Infrastructure Financing Tools (LIFT) Act instrument Legislation introduced by Rep. Sewell to expand bond financing for local governments and nonprofits. 0 facts 0 conns 6 sources
MA Medicare Ambulance Access, Fraud Prevention, and Reform Act instrument Legislation co-introduced by Terri Sewell to stabilize Medicare reimbursement for ambulance services. 0 facts 0 conns 6 sources
PA Personal Health Investment Today (PHIT) Act instrument Federal legislation to allow HSA/FSA funds to cover fitness expenses. 0 facts 2 conns 6 sources
PA Protecting Access to Ground Ambulance Medical Services Act instrument Bipartisan legislation introduced in multiple sessions (2021, 2023, 2025) to extend or make permanent Medicare 'add-on' payments for ambulance providers. 0 facts 1 conns 6 sources
PA Protecting America's Seniors' Access to Care Act instrument Legislative bill (H.R. 7513) aimed at barring CMS from finalizing nursing home staffing minimum regulations. 0 facts 1 conns 6 sources
R2 Resident Physician Shortage Reduction Act of 2025 instrument Bipartisan bill introduced by Sewell and Brian Fitzpatrick to add 14,000 Medicare-supported residency slots. 0 facts 0 conns 6 sources
S. S.4638 instrument Senate-originated National Defense Authorization Act for Fiscal Year 2025 0 facts 0 conns 6 sources
SD Section 1071 of Dodd-Frank instrument Small business lending data collection rule requiring financial institutions to report demographic data on credit applications. 0 facts 1 conns 6 sources
SA Strengthening Health Care and Lowering Prescription Drug Costs Act instrument 2019 bipartisan bill restricting anti-competitive pharma behavior; Steil voted against 0 facts 1 conns 0 sources
← Prev1234